▼ 1.15%
prev close
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Congressional Trades
23
All tracked trades
Members Trading
12
Unique members
Net Activity
-5
9 buys · 14 sells
Members Who Traded This Stock
23 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-12-08 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 79d ago | — | |
| 2025-10-30 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 132d ago | — | |
| 2025-08-22 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 202d ago | — | |
| 2025-08-11 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 202d ago | — | |
| 2025-07-22 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 232d ago | — | |
| 2025-07-11 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 225d ago | — | |
| 2025-04-17 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 323d ago | — | |
| 2025-04-03 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 323d ago | — | |
| 2025-02-25 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 371d ago | — | |
| 2025-01-24 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 79d ago | — | |
| 2024-09-04 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 573d ago | — | |
| 2023-11-10 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 577d ago | — | |
| 2023-10-24 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 875d ago | — | |
| 2023-09-08 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 905d ago | — | |
| 2023-09-06 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 905d ago | — | |
| 2023-07-14 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 963d ago | — | |
| 2023-03-24 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 1078d ago | — | |
| 2023-02-07 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 1112d ago | — | |
| 2023-01-31 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 1133d ago | — | |
| 2023-01-20 | ABBVABBVIE INC. | Sell | $1,001 - $15,000 | 1140d ago | — | |
| 2022-06-16 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 1364d ago | — | |
| 2022-03-17 | ABBVABBVIE INC. | Buy | $1,001 - $15,000 | 1446d ago | — | |
| 2020-05-12 | ABBVABBVIE INC. | Buy | $15,001 - $50,000 | 966d ago | — |
2025-12-08
Julia Letlow
ABBV
Amount
$1,001 - $15,000
Filed
79d ago
2025-10-30
Lisa McClain
ABBV
Amount
$1,001 - $15,000
Filed
132d ago
2025-08-22
John Boozman
ABBV
Amount
$1,001 - $15,000
Filed
202d ago
2025-08-11
John Boozman
ABBV
Amount
$1,001 - $15,000
Filed
202d ago
2025-07-22
Lisa McClain
ABBV
Amount
$1,001 - $15,000
Filed
232d ago
2025-07-11
Ritchie John Torres
ABBV
Amount
$1,001 - $15,000
Filed
225d ago
2025-04-17
Josh Gottheimer
ABBV
Amount
$1,001 - $15,000
Filed
323d ago
2025-04-03
Josh Gottheimer
ABBV
Amount
$1,001 - $15,000
Filed
323d ago
2025-02-25
Rob Bresnahan
ABBV
Amount
$1,001 - $15,000
Filed
371d ago
2025-01-24
Julia Letlow
ABBV
Amount
$1,001 - $15,000
Filed
79d ago
2024-09-04
John James
ABBV
Amount
$1,001 - $15,000
Filed
573d ago
2023-11-10
John James
ABBV
Amount
$1,001 - $15,000
Filed
577d ago
2023-10-24
Greg Stanton
ABBV
Amount
$1,001 - $15,000
Filed
875d ago
2023-09-08
Lois Frankel
ABBV
Amount
$1,001 - $15,000
Filed
905d ago
2023-09-06
Lois Frankel
ABBV
Amount
$1,001 - $15,000
Filed
905d ago
2023-07-14
Daniel Goldman
ABBV
Amount
$1,001 - $15,000
Filed
963d ago
2023-03-24
Josh Gottheimer
ABBV
Amount
$1,001 - $15,000
Filed
1078d ago
2023-02-07
Josh Gottheimer
ABBV
Amount
$1,001 - $15,000
Filed
1112d ago
2023-01-31
Daniel Goldman
ABBV
Amount
$1,001 - $15,000
Filed
1133d ago
2023-01-20
Josh Gottheimer
ABBV
Amount
$1,001 - $15,000
Filed
1140d ago
2022-06-16
Robert J. Wittman
ABBV
Amount
$1,001 - $15,000
Filed
1364d ago
2022-03-17
Josh Gottheimer
ABBV
Amount
$1,001 - $15,000
Filed
1446d ago
2020-05-12
Richard W. Allen
ABBV
Amount
$15,001 - $50,000
Filed
966d ago
Recent News
Powered by Polygon.io
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now
Trade Timeline
Congressional activity, newest first
Julia Letlow
2025-12-08 · Sale
$1,001 - $15,000
Lisa McClain
2025-10-30 · Purchase
$1,001 - $15,000
John Boozman
2025-08-22 · Sale
$1,001 - $15,000
John Boozman
2025-08-11 · Sale
$1,001 - $15,000
Lisa McClain
2025-07-22 · Sale
$1,001 - $15,000
Ritchie John Torres
2025-07-11 · Sale
$1,001 - $15,000
Josh Gottheimer
2025-04-17 · Sale
$1,001 - $15,000
Josh Gottheimer
2025-04-03 · Purchase
$1,001 - $15,000
Rob Bresnahan
2025-02-25 · Purchase
$1,001 - $15,000
Julia Letlow
2025-01-24 · Sale
$1,001 - $15,000
John James
2024-09-04 · Sale
$1,001 - $15,000
John James
2023-11-10 · Purchase
$1,001 - $15,000
Greg Stanton
2023-10-24 · Sale
$1,001 - $15,000
Lois Frankel
2023-09-08 · Sale
$1,001 - $15,000
Lois Frankel
2023-09-06 · Purchase
$1,001 - $15,000
Daniel Goldman
2023-07-14 · Sale
$1,001 - $15,000
Josh Gottheimer
2023-03-24 · Sale
$1,001 - $15,000
Josh Gottheimer
2023-02-07 · Sale
$1,001 - $15,000
Daniel Goldman
2023-01-31 · Purchase
$1,001 - $15,000
Josh Gottheimer
2023-01-20 · Sale
$1,001 - $15,000
Robert J. Wittman
2022-06-16 · Purchase
$1,001 - $15,000
Josh Gottheimer
2022-03-17 · Purchase
$1,001 - $15,000
Richard W. Allen
2020-05-12 · Purchase
$15,001 - $50,000